Overview

On-demand Silodosin 4mg vs Dapoxetine 60mg in Treatment of Primary Premature Ejaculation

Status:
COMPLETED
Trial end date:
2025-04-01
Target enrollment:
Participant gender:
Summary
Both Silodosin 4 mg and Dapoxetine 60 mg significantly improved IELT and sexual function scores in primary PE patients. However, Silodosin exhibited a more favorable tolerability profile with fewer side effects, making it a safer, clinically effective alternative.
Phase:
PHASE2
Details
Lead Sponsor:
Benha University
Treatments:
dapoxetine